Madrigal Pharmaceuticals share price logo

Madrigal Pharmaceuticals

NASDAQ: MDGL

Large Cap

$509.11

-0.33

(-0.06%)

Live

as on

Madrigal Pharmaceuticals Stock Performance

as on October 1, 2026 at 3:08 am IST

  • Day's Low

    Day's High

    $501.81
    $513.10
    downward going graph

    1.43%

    Downside

    0.78%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $393.61
    $615.00
    downward going graph

    22.69%

    Downside

    20.80%

    Upside

    downward going graph

Madrigal Pharmaceuticals share price movements today

Previous Close
$509.44
Open
$513.10
Volume
92.9K
Market Cap
$11.9B
Day's Low - High
$501.81 - $513.10
52 Week Low - High
$393.61 - $615.00

Madrigal Pharmaceuticals Historical Returns

1 Month Return
-4.56 %
3 Month Return
-5.12 %
1 Year Return
+ 11.07 %
3 Year Return
+ 248.84 %
5 Year Return
+ 538.48 %

Madrigal Pharmaceuticals Stock Fundamentals & Key Indicators

Check Madrigal Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.9B

EPS (TTM)

-12.89

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-40.11

Industry PE ratio

11.41

PEG Ratio

116.20

EBITDA

-298.8M

Revenue (TTM)

1.3B

Profit Margin

91.48%

Return On Equity TTM

-56.65%

Madrigal Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Madrigal Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$11.9B538.48%-40.1191.48%0.00%
StrongBuy$43.2B643.29%-22.770.00%0.00%
Neutral$78.8B-47.13%-24.72-12.57%0.00%
StrongBuy$133.4B189.75%30.3886.04%0.00%
Buy$81.1B24.01%17.9684.86%0.49%

Stock Returns calculator for Madrigal Pharmaceuticals Stock including INR - Dollar returns

The Madrigal Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Madrigal Pharmaceuticals investment value today

Current value as on today

₹1,19,732

Returns

₹19,732

(+19.73%)

Returns from Madrigal Pharmaceuticals Stock

₹10,999 (+11%)

Dollar Impact

₹8,732 (+8.73%)

Analyst Recommendation on Madrigal Pharmaceuticals Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.88888888888889% of analysts recommend a 'BUY' rating for Madrigal Pharmaceuticals. Average target price of $682.11

Madrigal Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Madrigal Pharmaceuticals.

What analysts predicted

25.36%UPSIDE

Target Price

$682.11

Current Price

$509.11

Analyzed by

9 Analysts

High

$739

Target

$682.11

Low

$543

Madrigal Pharmaceuticals target price $682.11, a slight upside of 25.36% compared to current price of $509.11. According to 9 analysts rating.

Indian Investors' Interest in Madrigal Pharmaceuticals Stock

Search interest for Madrigal Pharmaceuticals Stock has decreased by -68% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-68% versus previous 30 day period

Madrigal Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
14
62
103
137
212
287
321
311
364
Gross Profit
-
14
60
99
132
203
269
296
284
324
Operating Income
-152
-162
-116
-66
-79
-47
-113
-59
-92
-56
EBITDA
-143
-148
-102
-55
-69
-38
-106
-49
-86
-56
Interest Expense
3
3
3
3
3
3
7
8
7
-7
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-147
-151
-106
-59
-73
-42
-114
-58
-94
-57
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-147
-151
-106
-59
-73
-42
-114
-58
-94
-57
Net Profit Margin
0.00%
95.66%
96.54%
96.67%
96.71%
95.74%
93.69%
92.39%
91.38%
89.02%

Madrigal Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
180
958
Gross Profit
0
0
0
0
-
-
-
173
902
Operating Income
-31
-40
-94
-206
-242
-293
-380
-497
-300
EBITDA
-31
-32
-83
-201
-241
-290
-360
-450
-264
Interest Expense
-
-
-
-
-
3
12
14
22
Depreciation
0
0
0
0
0
0
0
1
1
Income Before Tax
-31
-32
-83
-202
-241
-295
-373
-465
-288
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-31
-32
-83
-202
-241
-295
-373
-465
-288
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
96.54%
94.14%

Madrigal Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-147
-151
-106
-59
-73
-42
-114
-58
-94
-57
Operating Cash Flow
-149
-134
-66
-104
-88
-47
79
-133
-167
23
Investing Cash Flow
98
-122
-202
-47
163
47
-206
27
192
34
Financing Cash Flow
573
134
7
19
8
1
236
8
2
3
Change in Cash
522
-122
-261
-132
83
2
109
-96
28
60

Madrigal Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-31
-32
-83
-202
-241
-295
-373
-465
-288
Operating Cash Flow
-22
-25
-41
-157
-183
-224
-324
-455
-189
Investing Cash Flow
-22
-380
30
159
-5
206
-502
-274
32
Financing Cash Flow
173
314
0
5
171
313
595
735
255
Change in Cash
129
-91
-10
7
-17
295
-231
5
98

Global Institutional Holdings in Madrigal Pharmaceuticals

Check out the Institutions with significant holdings in Madrigal Pharmaceuticals.

Funds
Holdings
Felix Baker
9.28%
Vanguard
6.74%
VANGUARD INDEX FUNDS
6.29%
John Paulson
5.80%
JANUS INVESTMENT FUND
4.91%

Madrigal Pharmaceuticals News & Key Events

    Insights on Madrigal Pharmaceuticals

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 3 years, MDGL stock has moved up by 248.8%

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, MDGL has outperformed top 5 stocks with highest market-cap in its industry

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 687.7% return, outperforming this stock by 676.6%

    About Madrigal Pharmaceuticals

    Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development phase, concentrating its efforts on discovering and commercializing innovative treatments for cardiovascular, metabolic, and liver disorders. Its most advanced drug candidate, resmetirom, functions as a liver-targeted selective thyroid hormone receptor-ß agonist, currently undergoing late-stage (Phase III) clinical trials for managing non-alcoholic steatohepatitis (NASH). The company's pipeline also features MGL-3745, which serves as a secondary or backup compound to resmetirom. Madrigal holds a collaborative agreement with Hoffmann-La Roche, encompassing research, development, and commercialization activities. The company's operations are based out of West Conshohocken, Pennsylvania.
    OrganisationMadrigal Pharmaceuticals
    Headquarters1001 Conshohocken State Road, West Conshohocken, PA, 19428, US
    IndustryBiotechnology
    CEOWilliam J. Sibold

    Key Management of Madrigal Pharmaceuticals

    Name

    Title

    Ms. Rita Thakkar

    Senior VP & Chief Accounting Officer

    Mr. William J. Sibold

    CEO, President & Director

    Dr. Rebecca A. Taub M.D.

    Founder, Senior Scientific & Medical Advisor and Director

    Ms. Mardi C. Dier

    Executive VP & CFO

    Ms. Shannon Kelley

    Executive VP, Chief Legal Officer & Corporate Secretary

    Ms. Carole Huntsman

    Executive VP & Chief Commercial Officer

    Dr. David Soergel M.D.

    Executive VP & Chief Medical Officer

    Mr. Mark Underwood

    Executive Vice President of Business Planning & Operations

    Mr. Ronald Filippo

    Executive VP & Chief Information Officer

    Ms. Tina E. Ventura

    Chief Investor Relations Officer

    FAQs

    What is Madrigal Pharmaceuticals share price today?

    Madrigal Pharmaceuticals share price today is $509.11 as on . Madrigal Pharmaceuticals share today touched a day high of $513.10 and a low of $501.81.

    What is the 52 week high and 52 week low for Madrigal Pharmaceuticals share?

    Madrigal Pharmaceuticals share touched a 52 week high of $615.00 on and a 52 week low of $393.61 on . Madrigal Pharmaceuticals stock price today i.e. is trending at $509.11,which is 17.22% down from its 52 week high and 29.35% up from its 52 week low.

    What is Madrigal Pharmaceuticals's market capitalisation today?

    Madrigal Pharmaceuticals market capitalisation is $0.01T as on .

    How to invest in Madrigal Pharmaceuticals Stock (MDGL) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Madrigal Pharmaceuticals on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy Madrigal Pharmaceuticals Stock (MDGL) from India?

    Indian investors can start investing in Madrigal Pharmaceuticals (MDGL) shares with as little as ₹95.83000183105469 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹958.30 in Madrigal Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Madrigal Pharmaceuticals share’s latest price of $509.11 as on September 30, 2026 at 9:38 pm IST, you will get 0.0196 shares of Madrigal Pharmaceuticals. Learn more about fractional shares .

    What are the returns that Madrigal Pharmaceuticals has given to Indian investors in the last 5 years?

    Madrigal Pharmaceuticals stock has given 538.48% share price returns and 29.42% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?